CellWell record HH-384757
The Role of Lipid Alteration in Multiple Sclerosis
Agnieszka Damiza-Detmer; Małgorzata Pawełczyk; Andrzej Głąbiński
2026
In plain language
Dyslipidemia in multiple sclerosis may stem from aberrant cholesterol metabolism following demyelination, correlating with blood-brain barrier dysfunction and inflammation.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-384757
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.